Clinical trial
An Investigational Drug Study In Patients With COPD (Chronic Obstructive…
NCT00132730 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00132730 |
|---|---|
| Title | An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005) |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK-0873 in Patients With COPD |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Diseases, Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | MK-0873 2.5 mg, MK-0873 1.25 mg, MK-0873 0.75 mg, Placebo to MK-0873, Usual Care |
| Enrollment | 604 |
| Start date | Jun 1, 2004 |
| Primary completion | Aug 17, 2005 |
| Completion | Aug 17, 2005 |
| First posted | Aug 22, 2005 |
| Last update posted | Oct 12, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: